Card image cap

Amy Klobuchar's Public Statements on Issue: Drugs

Office:
5

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 4 of 12
Date Title
04/20/2018 Klobuchar, Collins Introduce Legislation to Support Community Prevention and Treatment Efforts for Low-Income Families Impacted by the Opioid Epidemic
04/18/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
04/13/2018 Senators Collins, Klobuchar Introduce Bill to Authorize $50 Million Over Five Years for Community Organizations Responding to Opioid Addiction
04/12/2018 Klobuchar Highlights Efforts to Address the Dangers of Synthetic Drugs like Fentanyl at Judiciary Subcommittee Hearing
03/23/2018 Klobuchar Announces Congress Passes Major Funding to Combat the Opioid Epidemic
03/08/2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
03/05/2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
02/27/2018 Portman, Whitehouse, Capito, Klobuchar, Sullivan, Hassan, Cassidy & Cantwell Introduce CARA 2.0 Act
02/22/2018 Letter to Mr. Sundar Pichai, CEO, Google, Mr. Satya Nadella, CEO, Microsoft, Mr. Ben Silbermann, CEO and Co-Founder, Pinterest, and Ms. Mayer, CEO of Yahoo - Clamp Down on Illegal Online Drug Sales and Advertising
02/15/2018 Brown, Cornyn, Feinstein, Nelson, Klobuchar, Portman, Tillis, Ratcliffe, Rice Introduce Bill to Combat Drug-Facilitated Human Trafficking
12/01/2017 Klobuchar Statement on Minnesota Lawsuits Against Opioid Drug Manufacturers and Distributors
11/08/2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
11/07/2017 Letter to Mr. Brenton L. Saunders, CEO, Allergan plc - Monopoly Keeps Price of Drug High, Limits Competition
11/03/2017 Letter to the Hon. Donald J. Trump, President - Support Funding to Stem Opioid Epidemic
11/01/2017 President's Commission on Combating Drug Addiction and the Opioid Crisis Includes Bipartisan Klobuchar Bills in Recommendations to the Administration
10/26/2017 Klobuchar Statement on Declaration of the Opioid Epidemic as a Public Health Emergency
10/25/2017 Letter to President Donald Trump - Senators Call on President to Allow Government to Negotiate Lower Prices for Naloxone, a Life-Saving Opioid Overdose Reversal Drug
10/25/2017 Letter to President Donald J. Trump - Allow Government to Negotiate Lower Prices for Naloxone
10/20/2017 Letter to Eric Hargan, Acting Secretary of Health and Human Services, Robert Patterson, Acting Administrator of Drug Enforcement Administration - Ensuring Patient Access and Effective Drug Enforcement Act
10/10/2017 Klobuchar Statement on Reports of K2 Synthetic Drug Overdoses
09/08/2017 Klobuchar Statement on Report Showing Drug Overdose Deaths on the Rise in Minnesota
07/19/2017 Letter to Richard Baum, Acting Director Office of National Drug Control Policy - Deliver a Strategy to Battle Opioid Addiction
07/11/2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
07/07/2017 Klobuchar Statement on Reports of Decline in Rate of Opioid Prescribing
07/03/2017 Klobuchar Presses Three Pharmaceutical Companies for Action on High Insulin Prices; Urges Vigilance Against Anticompetitive Conduct
Page 4 of 12
arrow_upward